The concentrations of insoluble tau from AD-tau-treated neuronal cell lysates raised significantly over time and demonstrated different aggregation kinetics for each individual AD-tau inoculum (Fig. 5Ba). This evidence concerns the gene MAPT and Alzheimer disease.